Viewing Study NCT01258192


Ignite Creation Date: 2025-12-24 @ 3:20 PM
Ignite Modification Date: 2026-01-01 @ 7:55 AM
Study NCT ID: NCT01258192
Status: COMPLETED
Last Update Posted: 2014-07-29
First Post: 2010-12-03
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: Neoadjuvant Chemotherapy With Nab-paclitaxel Plus Cisplatin for Stage Ⅱ-Ⅲ Esophageal Cancer Patients
Sponsor: Zhejiang Cancer Hospital
Organization:

Study Modules

Identification Module Status Module Sponsor Collaborators Module Oversight Module Description Module Conditions Module Design Module Arms Interventions Module Outcomes Module Eligibility Module Contacts Locations Module References Module